Cat antigen desensitization reduces allergic rhinoconjunctivitis symptoms

NEW YORK (Reuters Health) – Desensitization with a Fel d 1-derived peptide antigen (Cat-PAD) reduces
allergic rhinoconjunctivitis symptoms up to a year after the start of dosing.
Source: Modern Medicine: Optometry